Avaliação farmacocinética e farmacodinânica de meropenem e vancomicina em pacientes submetidos à diálise estendida de baixa eficiência (SLED)

Avaliação farmacocinética e farmacodinânica de meropenem e vancomicina em pacientes submetidos à diálise estendida de baixa eficiência (SLED)

INTRODUÇÃO: A combinação de sepse e insuficiência renal com necessidade de diálise é bastante comum nas Unidades de Terapia Intensiva e esta situação tem elevada mortalidade. Um desafio neste cenário é prescrever a dose correta dos antimicrobianos para o tratamento destas infecções. Em pacientes crí...

Full description

Bibliographic Details
Main Author:	Oliveira, Maura Salaroli de
Other Authors:	Levin, Anna Sara Shafferman
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2017
Subjects:	Critical care Diálise estendida de baixa eficiência anti-infecciosos/administração e dosagem Farmacocinética Farmadodinâmica Insuficiência renal Low-efficiency dialysis sustained anti-infective agents/administration e dosage Meropenem Pacientes críticos Pharmacodynamics Pharmacokinetics Renal insufficiency Vancomicina Vancomycin
Online Access:	http://www.teses.usp.br/teses/disponiveis/5/5134/tde-14112017-154634/

Similar Items

Avaliação farmacocinética e farmacodinânica de meropenem e vancomicina em pacientes submetidos à diálise estendida de baixa eficiência (SLED)
by: Maura Salaroli de Oliveira
Published: (2017)

Modelagem PK/PD na terapia antimicrobiana com carbapenêmico em pacientes sépticos críticos grandes queimados. \"Estudo da efetividade do meropenem administrado através de infusão intermitente versus estendida\"
by: Kupa, Leonard de Vinci Kanda
Published: (2019)

Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
by: Xiangqing Song, et al.
Published: (2019-11-01)

Farmacocinética do Meropenem infundido por 3 horas em pacientes criticamente enfermos em terapia renal substitutiva contínua
by: Leusin, Fabiane
Published: (2012)

Farmacocinética do Meropenem infundido por 3 horas em pacientes criticamente enfermos em terapia renal substitutiva contínua
by: Leusin, Fabiane
Published: (2012)

Farmacocinética do Meropenem infundido por 3 horas em pacientes criticamente enfermos em terapia renal substitutiva contínua
by: Leusin, Fabiane
Published: (2012)

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
by: Eric Wenzler, et al.
Published: (2020-10-01)

Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
by: Yixue Wang, et al.
Published: (2021-08-01)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
by: Sonia Luque, et al.
Published: (2021-06-01)

Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?
by: Silvia Corcione, et al.
Published: (2020-03-01)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
by: Brenda Zylbersztajn, et al.
Published: (2021-08-01)

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
by: Hui-Ying Zhao, et al.
Published: (2017-01-01)

A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit
by: Carlos R.V. Kiffer, et al.

Avaliação da remoção do antimicrobiano Vancomicina pelos diferentes métodos de diálise em pacientes com lesão renal aguda associada à sepse.
by: Freitas, Fernanda Moreira de
Published: (2018)

Appropriate Use of Meropenem: A Pharmacy Intervention
by: Stacey Abbott, et al.
Published: (2014)

Meropenem Induced Skin Drug Eruption in Infectious Mononucleosis: Immunological Phenomena or Non-immunological Phenomena?
by: Atousa Hakamifard, et al.
Published: (2020-01-01)

Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
by: Renata Černá Pařízková, et al.
Published: (2021-07-01)

Meropenem: A possible new culprit in eosinophilic lung diseases
by: Nathalie Abi Hatem, et al.
Published: (2017-01-01)

Farmacocinética da vancomicina em pacientes no período pós-operatório cardíaco
by: Carla Viotto Belli
Published: (2000)

Farmacocinética da vancomicina em pacientes no período pós-operatório cardíaco
by: Belli, Carla Viotto
Published: (2000)

Combined Use of Vancomycin and Meropenem in Patient with Acute Intermittent Porphyria: A Case Report
by: İrfan ŞENCAN, et al.
Published: (2004-09-01)

Clinical Pharmacology of Meropenem in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2016-11-01)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
by: Mohd H. Abdul-Aziz, et al.
Published: (2017-11-01)

Meropenem Resistance among Acinetobacter Positive Clinical Samples in a Tertiary Care Centre in Nepal: A Descriptive Cross-sectional Study
by: Nisha Sharma, et al.
Published: (2021-09-01)

Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
by: Stephan Braune, et al.
Published: (2018-01-01)

Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation
by: Matthias Gijsen, et al.
Published: (2021-04-01)

Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu
by: Oliveira, Juliana da Silva [UNESP]
Published: (2016)

The Appropriateness of Antibiotic Therapy in Patients Initiated on Meropenem in a University-Affiliated Hospital
by: Wolken, Kathryn, et al.
Published: (2011)

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Evolución clínica de la endocarditis infecciosa en pacientes tratados con Meropenem
by: Mariam Gonzalez Gorrin, et al.
Published: (2020-09-01)

Vancomycin pharmacokinetics in preterm infants Farmacocinética da vancomicina em neonatos pré-termo
by: Jose Kleber Kobol Machado, et al.
Published: (2007-01-01)

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
by: Adela Benítez-Cano, et al.
Published: (2020-02-01)

The In vitro Activity of Meropenem to Nosocomial Pseudomonas aeruginosa Isolates
by: Mustafa ÖZYURT, et al.
Published: (1998-09-01)

Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria
by: Amol T. Kothekar, et al.
Published: (2020-01-01)

Meropenem utilization evaluation in a referral teaching hospital in Iran
by: Peyman Naderi, et al.
Published: (2018-01-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Santos Sigrid S., et al.
Published: (2001-01-01)

Treatment of nosocomial pneumonia: an experience with meropenem
by: Sigrid S. Santos, et al.

Removal of Meropenem by using Lemna minor
by: Noora Saad, et al.
Published: (2021-10-01)

Evaluation of Resistance Mechanisms to Meropenem in Pseudomonas aeruginosa Isolates
by: Özgül KISA, et al.
Published: (1998-12-01)

Population pharmacokinetics of meropenem in critically ill infant patients
by: Wanlika Yonwises, et al.
Published: (2021-10-01)